Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zymeworks Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

2 Biotech Stocks That Could Make You Richer ↗

July 14, 2023

These biotech companies are seeing a spike in revenue growth.

Via The Motley Fool

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now ↗

July 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

Via InvestorPlace

Zymeworks Announces Participation in Upcoming Investor Conference

July 03, 2023

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Appoints New Director

June 29, 2023

From Zymeworks Inc.

Via GlobeNewswire

7 Analysts Have This to Say About Zymeworks ↗

June 06, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

May 29, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About Zymeworks ↗

May 18, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

April 10, 2023

Via Benzinga

Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

June 26, 2023

From Zymeworks Inc.

Via GlobeNewswire

Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying ↗

June 22, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

The 3 Most Undervalued Growth Stocks for Your June Buy List ↗

June 11, 2023

Sometimes you can get the best of both worlds in the equities sector, which should draw interest for these undervalued growth stocks.

Via InvestorPlace

3 Cheap Growth Stocks That Are Too Good to Pass Up ↗

June 05, 2023

These top bargain growth stocks are all priced under $10 a share and offer real upside potential for investors.

Via InvestorPlace

Zymeworks Announces Participation in Upcoming Investor Conferences

June 01, 2023

From Zymeworks Inc.

Via GlobeNewswire

What 7 Analyst Ratings Have To Say About Zymeworks ↗

March 31, 2023

Via Benzinga

Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact ↗

March 20, 2023

Via Benzinga

Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer

May 18, 2023

From Zymeworks Inc.

Via GlobeNewswire

Top 5 Health Care Stocks That May Collapse In Q2 ↗

May 10, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results

May 08, 2023

From Zymeworks Inc.

Via GlobeNewswire

Earnings Scheduled For May 8, 2023 ↗

May 08, 2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.

Via Benzinga

Analyst Ratings for Zymeworks ↗

March 08, 2023

Via Benzinga

Zymeworks Announces Participation in Upcoming Investor Conferences

May 01, 2023

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting

April 18, 2023

From Zymeworks Inc.

Via GlobeNewswire

The 7 Most Undervalued Stocks You Need to Know About ↗

April 18, 2023

Given the risks targeting highly popular trades right now, the most undervalued stocks to buy may offer greater mileage.

Via InvestorPlace

Zymeworks To Host First Quarter 2023 Results Conference Call

April 17, 2023

From Zymeworks Inc.

Via Business Wire

Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors

April 10, 2023

From Zymeworks Inc.

Via Business Wire

Zymeworks Announces Participation in Upcoming Investor Conferences

April 03, 2023

From Zymeworks Inc.

Via Business Wire

Zymeworks to Present Updated Data on Multiple Product Candidates at the American Association for Cancer Research (AACR) Annual Meeting

March 14, 2023

From Zymeworks Inc.

Via Business Wire

Zymeworks Offers Hope for More than Just Long-Term Investors

March 09, 2023

Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher

Via MarketBeat

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket ↗

March 08, 2023

Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1...

Via Benzinga

Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results

March 07, 2023

From Zymeworks Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.